Literature DB >> 15134192

Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAART.

Andrea Antinori1, Alessandro Cozzi-Lepri, Adriana Ammassari, Maria Paola Trotta, David Nauwelaers, Richard Hoetelmans, Rita Murri, Sara Melzi, Pasquale Narciso, Paola Nasta, Mauro Zaccarelli, Paola Santopadre, Jacopo Vecchiet, Crescenzo Maria Izzo, Antonella d'Arminio Maonforte.   

Abstract

We studied the predictive value of self-reported adherence and plasma drug concentrations on virological rebound to HAART. Among 238 participants in the AdICoNA study who had viral load < or = 500 copies/ml, 42 (17.6%) experienced virological rebound by 96 weeks. Both self-reported non-adherence and sub-optimal concentration were independently associated with a higher risk of virological rebound.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15134192

Source DB:  PubMed          Journal:  Antivir Ther        ISSN： 1359-6535


  11 in total

Review 1.  Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management.

Authors:  Jane M Simoni; Ann E Kurth; Cynthia R Pearson; David W Pantalone; Joseph O Merrill; Pamela A Frick
Journal:  AIDS Behav       Date:  2006-05

2.  Therapeutic drug monitoring of atazanavir: surveillance of pharmacotherapy in the clinic.

Authors:  John E Ray; Debbie Marriott; Mark T Bloch; Andrew J McLachlan
Journal:  Br J Clin Pharmacol       Date:  2005-09       Impact factor: 4.335

3.  Italian consensus statement on management of HIV-infected individuals with advanced disease naïve to antiretroviral therapy.

Authors:  A Antinori; A Ammassari; C Torti; P Marconi; M Andreoni; G Angarano; S Bonora; A Castagna; R Cauda; M Clerici; A d'Arminio Monforte; A De Luca; G Di Perri; M Galli; E Girardi; A Gori; A Lazzarin; S Lo Caputo; F Mazzotta; F Montella; C Mussini; C F Perno; M Puoti; G Rizzardini; S Rusconi; V Vullo; G Carosi
Journal:  Infection       Date:  2009-05-28       Impact factor: 3.553

4.  Cost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern Italy.

Authors:  Giuliano Rizzardini; Paolo Bonfanti; Laura Carenzi; Massimo Coen; Giovanna Orlando; Sergio Di Matteo; Giorgio L Colombo
Journal:  Ther Clin Risk Manag       Date:  2012-09-17       Impact factor: 2.423

5.  Cost-effectiveness analysis of initial HIV treatment under Italian guidelines.

Authors:  Giorgio L Colombo; Vincenzo Colangeli; Antonio Di Biagio; Sergio Di Matteo; Claudio Viscoli; Pierluigi Viale
Journal:  Clinicoecon Outcomes Res       Date:  2011-10-31

6.  Self-reported adherence supports patient preference for the single tablet regimen (STR) in the current cART era.

Authors:  Gaetana Sterrantino; Lucia Santoro; Dario Bartolozzi; Michele Trotta; Mauro Zaccarelli
Journal:  Patient Prefer Adherence       Date:  2012-06-07       Impact factor: 2.711

Review 7.  Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines.

Authors:  Giorgio L Colombo; Sergio Di Matteo; Andrea Antinori; Massimo Medaglia; Silvia Murachelli; Giuliano Rizzardini
Journal:  Clinicoecon Outcomes Res       Date:  2013-10-03

8.  Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors.

Authors:  Anna Rychter; Piotr Jerzmanowski; Adam Hołub; Zofia Specht-Szwoch; Violetta Kalinowska; Urszula Tęgowska; Ilona Seferyńska; Agnieszka Kołkowska-Leśniak; Ewa Lech-Marańda; Joanna Góra-Tybor
Journal:  Med Oncol       Date:  2017-04-25       Impact factor: 3.064

9.  Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy.

Authors:  Patrick S Sullivan; Michael L Campsmith; Glenn V Nakamura; Elin B Begley; Jeffrey Schulden; Allyn K Nakashima
Journal:  PLoS One       Date:  2007-06-20       Impact factor: 3.240

10.  Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting.

Authors:  Giorgio L Colombo; Antonella Castagna; Sergio Di Matteo; Laura Galli; Giacomo Bruno; Andrea Poli; Stefania Salpietro; Alessia Carbone; Adriano Lazzarin
Journal:  Ther Clin Risk Manag       Date:  2013-12-18       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.